First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial
Condition(s):Advanced Non-squamous Non-Small-Cell Lung CancerLast Updated:December 13, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Non-squamous Non-Small-Cell Lung CancerLast Updated:December 13, 2022Recruiting
Condition(s):Non-Squamous Non Small Cell Lung CancerLast Updated:December 27, 2023Recruiting
Condition(s):Non Squamous, Non-small-cell Lung CancerLast Updated:April 6, 2021Terminated
Condition(s):Non-squamous Non-small-cell Lung CancerLast Updated:May 6, 2023Recruiting
Condition(s):Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Last Updated:October 13, 2011Completed
Condition(s):Non-Small Cell Lung CancerLast Updated:December 21, 2023Recruiting
Condition(s):Non Squamous Cell Lung Cancer; Non Small Cell Lung CancerLast Updated:May 17, 2017Terminated
Condition(s):Non-squamous Cell Non-Small Cell Lung CancerLast Updated:December 19, 2018Unknown status
Condition(s):Non Squamous Non Small Cell Lung Cancer; EGFR Positive Non-small Cell Lung CancerLast Updated:August 1, 2023Not yet recruiting
Condition(s):Non-squamous Non-small Cell Lung CancerLast Updated:June 20, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.